Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/18/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Gordon Chiu

Wrong Dr. Gordon Chiu?

President and Chief Technology Of...

Grafoid Inc
912-130 Albert Street
Ottawa , Ontario K1P 5G4
Canada

Company Description: Grafoid's mission creates markets for our graphene investments to institutional partners, and we provide technical advisory and consulting services to miners,...   more
Background

Employment History

Board Memberships and Affiliations

  • Board Member
    Vois Inc.
  • Lead Advisor
    Calevia Inc
  • Advisor and Chief Scientist
    TriAusMin Limited

Education

  • BS degree summa cum laude , chemistry
    Rensselaer Polytechnic Institute
  • MS degree with honors , chemistry
    Seton Hall University
  • MD/PhD candidate
    Mount Sinai School of Medicine
  • B.S. degree summa cum laude , chemistry
    Rensselaer Polytechnic Institute
  • M.S. degree with honors , chemistry
    Seton Hall University
122 Total References
Web References
Gordon Chiu, B.Sci., MSci, ...
calevia.com, 18 Mar 2015 [cached]
Gordon Chiu, B.Sci., MSci, f-MSTP, ND
...
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. He is co-founder at Grafoid Inc., where he is currently President and Chief Technology Officer. Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and its subsidiaries, as well as the development of graphene applications with Grafoid's joint venture application development partners. He is also Chief Scientist at Focus Graphite Inc. Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia.
Dr. Chiu holds a B.Sc. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute, graduated with a M.Sc. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program (MSTP) at the Mount Sinai School of Medicine. Dr. Chiu jointly combined his cumulative training with a Doctor of Naturopathic Medicine (ND) degree from the University of Bridgeport.
Graphite Stocks | Focus Graphite
graphitestocks.com, 19 Dec 2013 [cached]
Dr. Gordon Chiu, B.Sci, M.Sci, MSTP recipient, ND.
Dr. Gordon Chiu is Vice President and Chief Scientist of Grafoid inc., Focus Metals' joint venture to develop, patent and secure the global rights for specific graphene technologies. The joint venture is based in New York City.
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. A lecturer and corporate advisor, Dr Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and provides advice on project selection with a view to increasing overall shareholder value.
Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia. He holds a B.S. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute; graduated with an M.S. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program at the Mount Sinai School of Medicine. He jointly combined his cumulative training with an ND degree in naturopathic medicine from the University of Bridgeport.
Grafoid's technology - ...
www.grafoid.com, 5 Oct 2014 [cached]
Grafoid's technology - developed by the National University of Singapore and Grafoid's President, Chief Technology Officer and Founding Partner, Dr. Gordon Chiu - produces pristine, high-energy density MesoGraf™ functional graphene at significant gross margins.
...
Grafoid's 50% owned subsidiary, Graphite Zero Pte Ltd. is a private Singapore-based graphene research, development and manufacturing company, managed by the equity participation of Professor Loh Kian Ping, Dr. Chiu and Focus Graphite. Graphite Zero has entered into an exclusive agreement with the National University of Singapore to help commercialize graphene products using the patent-pending, simple low-cost process developed by the National University of Singapore's Graphene Research Centre and Grafoid's President, Chief Technology Officer and Founding Partner, Dr. Gordon Chiu.
National University of Singapore's Graphene Research Centre
The National University of Singapore's world-renowned Graphene Research Centre was created in 2010 for the conception, characterization, theoretical modeling, and development of transformative technologies based on graphene and is the IP holder of the MesoGraf™ production process. MesoGraf™ was developed by inventors Dr. Gordon Chiu, President, Chief Technology Officer and Founding Partner of Grafoid, and by Professor Loh Kian Ping of the National University of Singapore's (NUS) Graphene Research Centre. Research, pilot process and manufacturing are done in partnership with Graphite Zero, the University's first commercial graphene spinout company.
Nov 24, 2011: Quebec Exploration Conference, speech by Gary Economo
www.focusgraphite.com, 24 Nov 2011 [cached]
Dr. Gordon Chiu, the renowned American research scientist became our partner and agreed to act as Grafoid's Chief Scientist.
In the coming months, Grafoid will produce our company's first revenues from a graphene mass production process developed by Dr. Chiu and his colleagues - a process involving the extraction of graphene from our Lac Knife ore.
The quality and purity of our graphene, according to Dr. Chiu's research, and the ease of extraction of graphene from Lac Knife's graphite ore contributed to Grafoid's discovery of an environmentally friendly, inexpensive process that produces the highest quality graphene available to science today.
About-Management
www.calevia.com, 4 June 2014 [cached]
Gordon Chiu, B.Sci., MSci, f-MSTP, ND
...
Dr. Chiu is lead advisor to Calevia Inc. and will co-manage the project. He is Co-Founder and Vice-President of Grafoid Inc., a privately held Canadian corporation investing in graphene applications and economically scalable production processes for MesoGraf™ - the global standard for graphene - and MesoGraf™Xide, its trademark graphene oxide produced from raw, unprocessed graphite ore.
Dr. Chiu is also the lead scientist at Focus Graphite, a TSX Venture-listed graphite mining and graphene development company.
Other People with the name "Chiu":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.